Upregulated RIP3 Expression Potentiates MLKL Phosphorylation-Mediated Programmed Necrosis in Toxic Epidermal Necrolysis

Journal of Investigative Dermatology

Volumn 135, Issue 8, 2015, Pages 2021-2030

  Kim, Sue Kyung ^a   Kim, Woo Jung ^a   Yoon, Jung Ho ^a   Ji, Jae Hoon ^a   Morgan, Michael J ^b   Cho, Hyeseong ^a   Kim, You Chan ^a   Kim, You Sun ^a  

^a Ajou University School of Medicine   (South Korea)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DABRAFENIB; MITOGEN ACTIVATED PROTEIN KINASE; MIXED LINEAGE KINASE DOMAIN LIKE PROTEIN; PEPTIDES AND PROTEINS; REACTIVE OXYGEN METABOLITE; RECEPTOR INTERACTING PROTEIN KINASE 3; UNCLASSIFIED DRUG; IMIDAZOLE DERIVATIVE; MLKL PROTEIN, HUMAN; OXIME; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SKIN DEFECT; TOXIC EPIDERMAL NECROLYSIS; UPREGULATION; ADULT; BIOPSY; CELL CULTURE; CELL JUNCTION; CHILD; DRUG EFFECTS; EPIDERMIS; METABOLISM; MIDDLE AGED; NECROSIS; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PRESCHOOL CHILD; SKIN; STEVENS JOHNSON SYNDROME; VERY ELDERLY;

ADULT; AGED, 80 AND OVER; APOPTOSIS; BIOPSY; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; EPIDERMIS; HUMANS; IMIDAZOLES; IN VITRO TECHNIQUES; INTERCELLULAR JUNCTIONS; KERATINOCYTES; MIDDLE AGED; NECROSIS; OXIMES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SKIN; STEVENS-JOHNSON SYNDROME; UP-REGULATION;

EID: 84937635416     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.90     Document Type: Article

References (47)

1. Abe R (2008) Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases. J Dermatol Sci 52:151-9
2. Bonnet MC, Bagot M, Bensussan A (2013) Apoptotic and necroptotic cell death in cutaneous inflammation. Eur J Dermatol. e-pub ahead of print 7 April 2013
3. Bonnet MC, Preukschat D, Welz PS et al. (2011) The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 35:572-82
4. Cai Z, Jitkaew S, Zhao J et al. (2014) Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 16:55-65
5. Chang CC, Too CL, Murad S et al. (2011) Association of HLA-B∗1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population. Int J Dermatol 50: 221-4
6. Chen X, Li W, Ren J et al. (2014) Translocation of mixed lineage kinase domainlike protein to plasma membrane leads to necrotic cell death. Cell Res 24: 105-21
7. Chung WH, Hung SI, Yang JY et al. (2008) Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14:1343-50
8. Declercq W, Vanden Berghe T, Vandenabeele P (2009) RIP Kinases at the Crossroads of Cell Death and Survival. Cell 138:229-32
9. Degterev A, Hitomi J, Germscheid M et al. (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4: 313-21
10. Downey A, Jackson C, Harun N et al. (2012) Toxic epidermal necrolysis: review of pathogenesis and management. J Am Acad Dermatol 66: 995-1003
11. Feoktistova M, Geserick P, Kellert B et al. (2011) cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 43: 449-63
12. Galluzzi L, Vitale I, Abrams JM et al. (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19:107-20
13. Geserick P, Hupe M, Moulin M et al. (2009) Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol 187:1037-54
14. Ghislain PD, Roujeau JC (2002) Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 8:5
15. Kaczmarek A, Vandenabeele P, Krysko DV (2013) Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38:209-23
16. Kaiser WJ, Upton JW, Long AB et al. (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471:368-72
17. Kamata H, Honda S, Maeda S et al. (2005) Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120:649-61
18. Kaniwa N, Saito Y, Aihara M et al. (2008) HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 9:1617-22
19. Kim SH, Lee KW, Song WJ et al. (2011) Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans. Epilepsy Res 97:190-7
20. Kim YS, Morgan MJ, Choksi S et al. (2007) TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 26:675-87
21. Kovalenko A, Kim JC, Kang TB et al. (2009) Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J Exp Med 206: 2161-77
22. Kroncke KD, Fehsel K, Kolb-Bachofen V (1997) Nitric oxide: cytotoxicity versus cytoprotection-how, why, when, and where? Nitric Oxide 1:107-20
23. Li JX, Feng JM, Wang Y et al. (2014a) The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury. Cell Death Dis 5:e1278
24. Li JX, Feng JM, Wang Y et al. (2014b) The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury. Cell Death Dis 5:e1278
25. Man CB, Kwan P, Baum L et al. (2007) Association between HLA-B∗1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 48:1015-8
26. Mehta TY, Prajapati LM, Mittal B et al. (2009) Association of HLA-B∗1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol 75:579-82
27. Murata J, Abe R, Shimizu H (2008) Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment. J Allergy Clin Immunol 122:992-1000
28. Oberst A, Dillon CP, Weinlich R et al. (2011) Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471: 363-7
29. Palmetshofer A, Zechner D, Luger TA, Barta A (1995) Splicing variants of the human growth hormone mRNA: detection in pituitary, mononuclear cells and dermal fibroblasts. Mol Cell Endocrinol 113:225-34
30. Panayotova-Dimitrova D, Feoktistova M, Ploesser M et al. (2013) cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis. Cell Rep 5:397-408
31. Pereira FA, Mudgil AV, Rosmarin DM (2007) Toxic epidermal necrolysis. J Am Acad Dermatol 56:181-200
32. Pierdomenico M, Negroni A, Stronati L et al. (2014) Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation. Am J Gastroenterol 109:279-87
33. Pincelli C, Sevignani C, Manfredini R et al. (1994) Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 103:13-8
34. Saito N, Qiao H, Yanagi T et al. (2014) An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions. Sci Transl Med 6:245ra95
35. Schwartz RA, McDonough PH, Lee BW (2013) Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol 69: 173:e1-13
36. Sun L, Wang H, Wang Z et al. (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148: 213-27
37. Vandenabeele P, Galluzzi L, Vanden Berghe T et al. (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11:700-14
38. Vanlangenakker N, Vanden Berghe T, Vandenabeele P (2012a) Many stimuli pull the necrotic trigger, an overview. Cell Death Differ 19:75-86
39. Vanlangenakker N, Vanden Berghe T, Vandenabeele P (2012b) Many stimuli pull the necrotic trigger, an overview. Cell Death Differ 19:75-86
40. Ventura JJ, Cogswell P, Flavell RA et al. (2004) JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev 18:2905-15
41. Viard-Leveugle I, Gaide O, Jankovic D et al. (2013) TNF-alpha and IFN-gamma are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis. J Invest Dermatol 133:489-98
42. Wang HY, Sun LM, Su LJ et al. (2014) Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 54:133-46
43. Wei CY, Chung WH, Huang HW et al. (2012) Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome. J Allergy Clin Immunol 129:1562-9
44. Wu W, Liu P, Li J (2012) Necroptosis: an emerging form of programmed cell death. Crit Rev Oncol Hematol 82:249-58
45. Wu YT, Tan HL, Huang Q et al. (2011) zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFalpha mediated by the PKC-MAPKs-AP-1 pathway. Cell Death Differ 18:26-37
46. Zhang H, Zhou X, McQuade T et al. (2011) Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471:373-6
47. Zhao J, Jitkaew S, Cai Z et al. (2012) Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci USA 109:5322-7